Goodwin Procter LLP advised Cathay Health, Polaris Partners, and Newpath Partners on the deal.Cathay Health, Polaris Partners, and Newpath Partners lead the Kojin Therapeutics’ $60 Million Series A…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
